BioPorto A/S | Income Statement

Fiscal year is January-December. All values DKK Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
16,625.00
18,705.00
20,383.00
20,720.00
25,155.00
26,016
Cost of Goods Sold (COGS) incl. D&A
7,643.00
5,676.00
5,120.00
5,329.00
7,331.00
8,640
Gross Income
8,982.00
13,029.00
15,263.00
15,391.00
17,824.00
17,376
SG&A Expense
28,784.00
28,285.00
28,022.00
40,438.00
54,318.00
59,157
EBIT
19,802.00
15,256.00
12,759.00
25,047.00
36,494.00
41,781
Non Operating Income/Expense
20.00
7.00
37.00
161.00
489.00
250
Interest Expense
2,147.00
44.00
311.00
77.00
106.00
113
Pretax Income
21,873.00
15,097.00
13,014.00
24,899.00
37,064.00
41,617
Income Tax
1,250.00
2,171.00
2,282.00
2,099.00
4,821.00
3,569
Consolidated Net Income
20,623.00
12,926.00
10,732.00
22,800.00
32,243.00
38,048
Net Income
20,623.00
12,926.00
10,732.00
22,800.00
32,243.00
38,048
Net Income After Extraordinaries
20,623.00
12,926.00
10,732.00
22,800.00
32,243.00
38,048
Net Income Available to Common
20,623.00
12,926.00
10,732.00
22,800.00
32,243.00
38,048
EPS (Basic)
0.26
0.11
0.09
0.17
0.22
0.24
Basic Shares Outstanding
79,137.00
117,861.00
121,639.00
131,012.00
144,549.00
156,640
EPS (Diluted)
0.26
0.11
0.09
0.17
0.22
0.24
Diluted Shares Outstanding
79,137.00
117,861.00
121,639.00
131,012.00
144,549.00
156,640
EBITDA
19,695.00
14,986.00
12,459.00
24,657.00
35,990.00
41,238
Non-Operating Interest Income
56.00
210.00
93.00
64.00
25.00
27

About BioPorto A/S

View Profile
Address
Tuborg Havnevej 15
Hellerup CR 2900
Denmark
Employees -
Website http://www.bioporto.com
Updated 07/08/2019
Bioporto A/S engages in the provision of diagnostic tests and antibodies to healthcare professionals in clinical and research settings. Its products specialize in coagulation, immunodeficiencies, diabetes, peptide hormones, and kidney diseases. Its portfolio consists of NGAL Test, NGAL ELISA kits, MBL ELISA kits, and AntibodyShop.